Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy



Status:Recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/9/2019
Start Date:January 2006
End Date:December 2020
Contact:Nimmi Ramanujam, Ph.D.
Phone:(919) 660-5307

Use our guide to learn which trials are right for you!

The objective of the proposed research is to develop new diagnostic modalities based on
optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of
breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery
part of the study, all patients scheduled to have a mastectomy or lumpectomy for the
treatment of breast cancer will be asked if they would be willing to participate in this
study. For the core needle biopsy part of the study, patients with a higher pre-probability
of cancer (based on mammography) will be recruited to increase the number of patients with
malignant lesions and enrolled in this investigation.


Inclusion Criteria:

- Patients having a needle biopsy of a breast mass

Exclusion Criteria:
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials